Resume Screening
Cancer Won’t Wait And Neither Should You
Resume Screening and Treatment for Cancer
The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
A coalition of 76 organizations have signed a letter to the public about the significant threat cancer poses to people’s health. The letter examines distressing trends showing a significant drop-off in recommended cancer screening and treatment during COVID-19 compared to pre-pandemic levels.
Cancer screening and treatment saves lives. Oncology experts agree that people should not delay any necessary prevention or care.
Additional Resources:
- NCCN COVID-19 Information
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Detection, Prevention, & Risk Reduction
- NCCN Guidelines for Breast Cancer Screening and Diagnosis
- NCCN Guidelines for Colorectal Cancer Screening
- NCCN Guidelines for Lung Cancer Screening
- NCCN Guidelines for Prostate Cancer Early Detection
- NCCN Guidelines for Patients®
- ACS Breast Cancer Screening Guidelines
- ACS Cervical Cancer Screening Guidelines
- ACS Colorectal Cancer Screening Guidelines
- ACS Lung Cancer Screening Guidelines